Advertisement

Topics

Pembro Plus Chemo: Practice-Changing for Nonsquamous mNSCLC

04:03 EDT 17 Apr 2018 | Medscape

Adding pembrolizumab to chemotherapy provided significant improvement in both overall and progression-free survival; the results have been hailed as practice-changing.
Medscape Medical News

Original Article: Pembro Plus Chemo: Practice-Changing for Nonsquamous mNSCLC

NEXT ARTICLE

More From BioPortfolio on "Pembro Plus Chemo: Practice-Changing for Nonsquamous mNSCLC"

Advertisement
Quick Search
Advertisement
Advertisement